Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Child Thriving After Becoming World's Youngest to Receive Gene Therapy for AADC Deficiency

      Cincinnati Children's Hospital Medical Center

      News provided by

      Cincinnati Children's Hospital Medical Center

      Nov 15, 2024, 16:24 ET

      Share this article

      Share this article


      Clinical Trial Success at Cincinnati Children's Supports Recent US FDA Approval for First Therapy to Directly Replace a Gene in the Brain 

      CINCINNATI, Nov. 15, 2024 /PRNewswire/ -- Sriansh Ojha was fully into his "terrible twos" on an April afternoon at Cincinnati Children's as he squealed and chased his older sister around the sunlit lobby of the Schubert Research Clinic.

      Continue Reading
      Lexington, Ky., resident Sriansh Ojha, now age 3,  was born with the rare genetic condition AADC deficiency.  As part of a clinical trial, Sriansh received a gene therapy treatment at Cincinnati Children's, which  transformed his life. At age 16 months at the time, Sriansh is the youngest patient in the world to receive this therapy. The US FDA granted accelerated approval of the treatment on Nov. 13, 2024. Photo credit: Cincinnati Children's.
      Lexington, Ky., resident Sriansh Ojha, now age 3, was born with the rare genetic condition AADC deficiency. As part of a clinical trial, Sriansh received a gene therapy treatment at Cincinnati Children's, which transformed his life. At age 16 months at the time, Sriansh is the youngest patient in the world to receive this therapy. The US FDA granted accelerated approval of the treatment on Nov. 13, 2024. Photo credit: Cincinnati Children's.

      Urging the laughing little boy to slow down was a parenting task that his mother, Bhawana Dhakal, and father, Tirtha Raj Ojha, of Lexington, Ky., felt profoundly pleased to perform. That's because in the first year of life, their son struggled to eat, could not lift his head off the bed, could not control his eye movements, and was not expected to ever be able to walk, much less run.

      "Gene therapy is a blessing I must say. You can see my child, before and after, and see that it works. He's a new person. He has a new life," Bhawana says.

      Sriansh was born with a rare genetic condition called AADC deficiency. In November 2022, at age 16 months, Sriansh became the youngest child in the world to receive a remarkably successful one-time gene therapy made by New Jersey-based PTC Therapeutics Inc. The treatment is now being marketed under the brand name KEBILIDI™.

      Sriansh, now 3 years old, was part of a clinical trial that led the U.S. Food and Drug Administration to approve the treatment on Nov. 13, 2024. The new treatment represents the first gene therapy approved in the United States that is directly administered to the brain. (Read the PTC media release)

      The therapy was developed about 15 years ago in Taiwan. Since 2010, when the first patient was treated, the therapy has been approved for commercial use by the European Union, the United Kingdom, and Israel. So far, only about 30 children worldwide have received the treatment.

      Donald Gilbert, MD, MS, a movement disorder expert with the Division of Neurology at Cincinnati Children's, played a central role in treating Sriansh and enrolling him the clinical trial.
      He saw, in full clinical detail, exactly how severe Sriansh's condition was before the therapy. Then he saw Sriansh for a follow-up visit three months after a high-tech surgical procedure delivered the gene therapy to his brain.

      "When I walked in and saw him, sitting up, completely on his own…" Gilbert pauses for a moment. "I will never forget that."

      "The way that a missing gene can be put in the brain in the place where it's needed, in a single-day treatment, and then produce what is needed for the rest of a child's life is amazing," he says.

      What is AADC deficiency?

      Aromatic l-amino acid decarboxylase (AADC) deficiency is a very rare inherited genetic disorder that disrupts how signals pass among nerve cells in the brain and beyond. Specifically, mutations in the gene DDC produce a damaged version of an enzyme called AADC, which is needed to produce dopamine and serotonin. Without adequate amounts of these neurotransmitters, the brain, spinal cord and peripheral nerves cannot properly function.

      Unusual problems begin appearing within months of birth and get worse. Symptoms include muscle weakness, unusual eye rolling, involuntary writhing movements, stiffening, and irritability. Affected infants often feed poorly, sleep badly and startle easily.

      In October 2021, when Sriansh was about three months old, his grandfather was the first to notice that Sriansh was having difficulties.

      "He had eye deviations, an arching back, and he used to sleep a lot. He was only awake like one or two hours and then would go back to sleep," Bhawana says. "Later, his aunt and a neighbor also said there is something wrong with Sriansh because normally kids don't twist their hand and arm the way he did."

      Chasing down the diagnosis

      Bhawana emigrated from Nepal to Los Angeles in 2013 with her parents and brother. She and Tirtha were married in Nepal in 2014, then the family moved to Lexington in 2016.

      Their first child was born healthy. So neither parent had any idea they were carrying rare variations in the same gene. Then they each passed along a copy of that gene variant to Sriansh, a variant that virtually no medical center looks for during prenatal testing.

      In Kentucky, several physicians worked to figure out what Sriansh had. The family took Sriansh to hospital admissions, EEG tests, MRI scans, and spinal taps to rule out seizure diseases and other possibilities. One doctor recommended travelling to a dystonia expert in New York.

      Eventually a complete genome test was ordered. But the family was told that processing the results would take three months. While waiting, Tirtha and Bhawana dove into online research and received various recommendations from far-flung friends and relatives. Their search led the family to Cincinnati Children's, about 100 miles north of the family's home.

      Sriansh was admitted for a stay that lasted nine days. Dr. Gilbert recognized some of the distinct symptoms during that visit, and rapidly obtained genetic test results confirmed that Sriansh had the rare condition. The care team prepared the family for the prospect of Sriansh facing a lifetime of 24/7 home care and countless more visits to medical offices and hospitals.

      But in this case, there was another option, available in only four centers in the United States.

      "I knew about a little bit about gene therapy," Tirtha says. "Back home I knew about a family that was raising money to get gene therapy for another rare disease. So, when Dr. Gilbert suggested gene therapy for Sriansh, I said, 'Of course, yes.'"

      Science fiction becomes reality

      Delivering this gene therapy required advanced technologies and a team of experts in neurosurgery and anesthesia.

      The treatment involves attaching a healthy version of the DDC gene to a modified virus called AAV9. The procedure calls for injecting more than 1 billion of these engineered viral vectors directly into the brain—specifically into the putamen, a small round structure deep in the brain that plays a vital role in motor control, speech articulation, cognitive function and more.

      Doing this for a child as young and small as Sriansh required changing the procedure, a task led by Sudhakar Vadivelu, DO, director of the Cerebrovascular Disease and Stroke Center at Cincinnati Children's. The modifications included changing the apparatus used during the procedure, moving the location and size of the burr hole used to expose the brain, and adjusting the anesthesia protocol. Vadivelu presented details about these modifications in November at a medical conference in Brazil.

      "It's one thing to say you have a 14-year-old or an 8-year-old. It's another thing to say you have an 8-month-old or a 16-month-old," Vadivelu says. "Adapting the procedure for the youngest children was important because the youngest patient has had one of the best outcomes. It's a clear early difference right off the bat."

      For Sriansh, the procedure was a complete success. After insertion, the engineered virus containing the missing DDC gene takes over. The virus invades targeted cells and sets up a tiny circular "factory" call an episome. This episome does not mingle with the brain cell's DNA. But it produces the DDC protein endlessly so the pathway to make dopamine is restored.

      Gilbert says being the youngest to receive the treatment helps explain why Sriansh has fared so well so far. "When they were working out how to do it in Taiwan, how much virus to give, and so on, all the children were older. Sriansh got it around 16 months of age. There also has been a little girl who got the surgery at around 20 months. She's also running around like he is," Gilbert says.

      For the Ojha family, being part of a clinical trial was intense, time-consuming and awe-inspiring all at the same time. So far, the outcome has been more than they dared to hope for Sriansh.

      "I think it's a miracle. It was a rough time, but it was worth it. I knew that no matter what I was going to try to save my child," Bhawana says. "This sounds funny but deep down I knew my child would be OK."

      Next steps
      Now that the therapy is approved, early diagnosis and early treatment will be crucial for maximizing treatment success for children with AADC deficiency. "It is now possible to diagnose this in a blood spot test, the same way we already diagnose PKU and other genetic conditions in a baby," Gilbert says.

      For children with other genetic brain disorders, this success suggests that gene therapy might be possible for them as well someday, Gilbert adds.

      Like the others receiving this new treatment, Sriansh will be followed for years to track how he meets developmental milestones, both for motor and cognitive functions. At 32 months, Sriansh was performing tasks at about the level of an 18-to-24-month-old, which to Gilbert's eyes meant that Sriansh had gained several months of progress in a matter of several weeks.

      How much further the progress will go, only time will tell. Bhawana is focused on how Sriansh does with talking.

      "He says Mama, Baba, Dada and he calls his sister DeeDee. But his words are not clear," she says. "He also tries to copy words we say. I think that is very promising. At least he's trying and that's why I'm really happy."

      Read more about research at Cincinnati Children's on our Research Horizons blog.

      SOURCE Cincinnati Children's Hospital Medical Center

      Note to editors

      Note for reporters: Video clips, sound bites and still images are available at this Hightail link: https://spaces.hightail.com/space/o3hjyXz5A9. Dr. Gilbert will be available on Monday 11/18 if interviews are requested. Please arrange via media contact Tim Bonfield.

      Modal title

      Also from this source

      10 Research Opportunities Poised to Advance Child Health

      10 Research Opportunities Poised to Advance Child Health

      Ten areas of pediatric research could drive the next generation of major advances in child health, according to a new special article in Pediatric...

      Gene Therapy Brings Hearing to Children with Inherited Deafness

      Gene Therapy Brings Hearing to Children with Inherited Deafness

      To see a 3-year-old boy who was born with profound deafness simply smile and point to the sounds coming from a nearby speaker felt like nothing short ...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Clinical Trials & Medical Discoveries

      Clinical Trials & Medical Discoveries

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.